home / stock / mvrbf / mvrbf short
Short Information | Medivir B (OTCMKTS:MVRBF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 24,180 |
Total Actual Volume | 26,170 |
Short Trends | |
---|---|
Cover Days | 2 |
Short Days | 17 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 1,209 |
Average Short Percentage | 88.68% |
Is there a MVRBF Short Squeeze or Breakout about to happen?
See the MVRBF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
08-29-2022 | $0.7 | $0.7 | $0.7 | $0.7 | 1,000 | 1,000 | 100% |
11-22-2021 | $1.24 | $1.24 | $1.24 | $1.24 | 5,000 | 5,000 | 100% |
06-15-2021 | $1.106 | $1.106 | $1.106 | $1.106 | 300 | 300 | 100% |
06-14-2021 | $1.1 | $1.1 | $1.1 | $1.1 | 875 | 875 | 100% |
01-28-2021 | $0.95 | $0.95 | $0.95 | $0.95 | 2,500 | 2,500 | 100% |
01-25-2021 | $1 | $1 | $1 | $1 | 1,800 | 1,800 | 100% |
12-01-2020 | $1.41 | $1.41 | $1.41 | $1.41 | 320 | 320 | 100% |
11-30-2020 | $1.42 | $1.42 | $1.42 | $1.42 | 1,005 | 1,005 | 100% |
10-28-2020 | $1.53 | $1.53 | $1.53 | $1.53 | 260 | 70 | 26.92% |
10-27-2020 | $1.75 | $1.75 | $1.75 | $1.75 | 1,000 | 1,000 | 100% |
10-26-2020 | $1.7 | $1.7 | $1.7 | $1.7 | 3,100 | 2,500 | 80.65% |
09-14-2020 | $1.63 | $1.63 | $1.63 | $1.63 | 160 | 60 | 37.5% |
06-24-2020 | $1.55 | $1.55 | $1.55 | $1.55 | 1,000 | 1,000 | 100% |
05-18-2020 | $1.58 | $1.58 | $1.58 | $1.58 | 150 | 150 | 100% |
05-15-2020 | $1.68 | $1.68 | $1.68 | $1.68 | 100 | 100 | 100% |
04-23-2020 | $1.45 | $1.39 | $1.45 | $1.39 | 2,100 | 2,000 | 95.24% |
04-13-2020 | $1.45 | $1.45 | $1.45 | $1.45 | 1,000 | 1,000 | 100% |
03-25-2020 | $1.17 | $1.35 | $1.35 | $1.17 | 1,500 | 500 | 33.33% |
03-23-2020 | $1.25 | $1.2 | $1.25 | $1.2 | 1,500 | 1,500 | 100% |
03-19-2020 | $1.3 | $1.3 | $1.3 | $1.3 | 1,500 | 1,500 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Medivir B Company Name:
MVRBF Stock Symbol:
OTCMKTS Market:
MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022 PR Newswire STOCKHOLM , Aug. 19, 2022 /PRNewswire/ -- The clinical development of fostrox remains the focus April - June Financial summary for the quarter Net turnover amoun...
Birinapant clinical study initiated by IGM Biosciences PR Newswire STOCKHOLM , Nov. 4, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR ) today announced that IGM Biosciences, Inc. has initiated its clinical study in solid cancers with birinapant (...
Medivir to present at the ProHearings shared Capital Markets Day PR Newswire STOCKHOLM , Oct. 11, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the ProHearings shared Capital Markets Day, Octo...